These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3912923)
1. Immunological bone marrow purging procedure in Burkitt's lymphoma. Evaluation by a liquid cell culture assay. Favrot MC; Philip I; Maritaz O; Garçon N; Philip T Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):455-62. PubMed ID: 3912923 [No Abstract] [Full Text] [Related]
2. The role of massive therapy with autologous bone marrow transplantation in Burkitt's lymphoma. Philip T; Pinkerton R; Hartmann O; Patte C; Philip I; Biron P; Favrot M Clin Haematol; 1986 Feb; 15(1):205-17. PubMed ID: 3516490 [TBL] [Abstract][Full Text] [Related]
3. Autologous bone-marrow transplantation for Burkitt's lymphoma: marrow purging with anti-Y 29/55 monoclonal antibody and complement. Baumgartner C; Delaleu B; Imbach P; Lüthy A; Odavic R; Brun del Re G; Bucher U; Forster HK; Hirt A; Wagner HP IARC Sci Publ; 1985; (60):435-40. PubMed ID: 3905594 [TBL] [Abstract][Full Text] [Related]
4. Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use. Kvalheim G; Sørensen O; Fodstad O; Funderud S; Kiesel S; Dörken B; Nustad K; Jakobsen E; Ugelstad J; Pihl A Bone Marrow Transplant; 1988 Jan; 3(1):31-41. PubMed ID: 3048468 [TBL] [Abstract][Full Text] [Related]
5. Bone marrow purging procedure in Burkitt lymphoma with monoclonal antibodies and complement: quantification by a liquid cell culture monitoring system. Favrot MC; Philip I; Philip T; Pinkerton R; Lebacq AM; Forster K; Adeline P; Doré JF Br J Haematol; 1986 Sep; 64(1):161-8. PubMed ID: 3756099 [TBL] [Abstract][Full Text] [Related]
6. Indication for bone-marrow harvesting and purging in Burkitt's Lymphoma: a three-year experience. Philip I; Philip T; Favrot MC; Biron P; Lenoir GM IARC Sci Publ; 1985; (60):441-5. PubMed ID: 3905595 [TBL] [Abstract][Full Text] [Related]
7. Massive chemotherapy with autologous bone marrow transplantation in Burkitt's lymphoma. A review of 50 patients treated in France. Philip T; Hartmann O; Pinkerton R; Patte C; Biron P; Soulliet G; Bernard JL; Freycon F; Bordigoni P; Laporte JP Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):521-9. PubMed ID: 2419957 [No Abstract] [Full Text] [Related]
8. Use of a liquid cell culture assay to quantify the elimination of Burkitt lymphoma cells from the bone marrow. Philip I; Favrot MC; Philip T J Immunol Methods; 1987 Feb; 97(1):11-7. PubMed ID: 3029226 [TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic classification of 28 Burkitt cell lines with monoclonal antibodies and reagent selection for bone-marrow purging. Favrot MC; Philip I; Philip T; Cabrillat H; Pinatel C; Doré JF; Lenoir GM IARC Sci Publ; 1985; (60):447-52. PubMed ID: 3905596 [No Abstract] [Full Text] [Related]
10. Immunomagnetic depletion of malignant cells from autologous bone marrow graft: from experimental models to clinical trials. Combaret V; Favrot MC; Chauvin F; Bouffet E; Philip I; Philip T J Immunogenet; 1989 Apr; 16(2):125-36. PubMed ID: 2687382 [TBL] [Abstract][Full Text] [Related]
11. Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies. Kvalheim G; Fodstad O; Pihl A; Nustad K; Pharo A; Ugelstad J; Funderud S Cancer Res; 1987 Feb; 47(3):846-51. PubMed ID: 3492268 [TBL] [Abstract][Full Text] [Related]
12. Purging of bone marrow with a cocktail of monoclonal antibodies (VIB-pool) for autologous transplantation. Zintl F; Reiners B; Thränhardt H; Hermann J; Fuchs D; Prager J Haematol Blood Transfus; 1987; 31():89-91. PubMed ID: 3327792 [No Abstract] [Full Text] [Related]
13. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement. Bast RC; De Fabritiis P; Lipton J; Gelber R; Maver C; Nadler L; Sallan S; Ritz J Cancer Res; 1985 Feb; 45(2):499-503. PubMed ID: 3967224 [TBL] [Abstract][Full Text] [Related]
14. [Cell cultures in Burkitt's lymphoma. Detection of residual disease and application to autologous graft purging]. Philip I; Favrot M Pathol Biol (Paris); 1988 Jan; 36(1):79-82. PubMed ID: 3283679 [TBL] [Abstract][Full Text] [Related]
15. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates. Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720 [TBL] [Abstract][Full Text] [Related]
16. Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement. De Fabritiis P; Bregni M; Lipton J; Greenberger J; Nadler L; Rothstein L; Korbling M; Ritz J; Bast RC Blood; 1985 May; 65(5):1064-70. PubMed ID: 3995166 [TBL] [Abstract][Full Text] [Related]
17. Lectin-binding properties of Burkitt's lymphoma cell lines: application to bone marrow purging. Mumcuoglu M; Favrot M; Slavin S Exp Hematol; 1990 Jan; 18(1):55-60. PubMed ID: 2298270 [TBL] [Abstract][Full Text] [Related]